Literature DB >> 15155984

Buruli ulcer disease in Cameroon rediscovered.

Jürgen Noeske1, Christopher Kuaban, Simona Rondini, Philippe Sorlin, Laura Ciaffi, Josephine Mbuagbaw, Françoise Portaels, Gerd Pluschke.   

Abstract

To assess the magnitude of the Buruli ulcer (BU) problem in Cameroon, we conducted a cross-sectional survey in the Nyong River basin and identified on clinical grounds a total of 436 cases of active or inactive BU (202 and 234, respectively). Swab specimens were taken from 162 active cases with ulcerative lesions and in 135 of these (83.3%) the clinical diagnosis was confirmed by the IS2404 polymerase chain reaction. Most lesions (93%) were located on the extremities, with lower limbs being twice as commonly involved as upper limbs. The age of patients with active BU ranged from 2 to 90 years with a median age of 14.5 years. Vaccination with bacilli Calmette-Guérin appeared to protect children against more severe forms of BU with multiple lesions. We conclude that in Cameroon BU is endemic, at least in the study area, and that a comprehensive control program for BU in Cameroon is urgently needed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15155984

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  38 in total

1.  Mycobacterium ulcerans infection (Buruli ulcer) on the face: a comparative analysis of 13 clinically suspected cases from the Democratic Republic of Congo.

Authors:  Delphin M Phanzu; Roger L Mahema; Patrick Suykerbuyk; Désiré-Hubert B Imposo; Linda F Lehman; Elie Nduwamahoro; Wayne M Meyers; Marleen Boelaert; Françoise Portaels
Journal:  Am J Trop Med Hyg       Date:  2011-12       Impact factor: 2.345

2.  Evaluation of decontamination methods and growth media for primary isolation of Mycobacterium ulcerans from surgical specimens.

Authors:  Dorothy Yeboah-Manu; Thomas Bodmer; Ernestina Mensah-Quainoo; Samuel Owusu; David Ofori-Adjei; Gerd Pluschke
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

3.  Infection with Mycobacterium ulcerans induces persistent inflammatory responses in mice.

Authors:  Martinha S Oliveira; Alexandra G Fraga; Egídio Torrado; António G Castro; João P Pereira; Adhemar Longatto Filho; Fernanda Milanezi; Fernando C Schmitt; Wayne M Meyers; Françoise Portaels; Manuel T Silva; Jorge Pedrosa
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

4.  Evidence for an intramacrophage growth phase of Mycobacterium ulcerans.

Authors:  Egídio Torrado; Alexandra G Fraga; António G Castro; Pieter Stragier; Wayne M Meyers; Françoise Portaels; Manuel T Silva; Jorge Pedrosa
Journal:  Infect Immun       Date:  2006-12-04       Impact factor: 3.441

5.  Seasonal and regional dynamics of M. ulcerans transmission in environmental context: deciphering the role of water bugs as hosts and vectors.

Authors:  Estelle Marion; Sara Eyangoh; Edouard Yeramian; Julien Doannio; Jordi Landier; Jacques Aubry; Arnaud Fontanet; Christophe Rogier; Viviane Cassisa; Jane Cottin; Agnès Marot; Matthieu Eveillard; Yannick Kamdem; Pierre Legras; Caroline Deshayes; Jean-Paul Saint-André; Laurent Marsollier
Journal:  PLoS Negl Trop Dis       Date:  2010-07-06

6.  Mycolactone-mediated inhibition of tumor necrosis factor production by macrophages infected with Mycobacterium ulcerans has implications for the control of infection.

Authors:  Egídio Torrado; Sarojini Adusumilli; Alexandra G Fraga; Pamela L C Small; António G Castro; Jorge Pedrosa
Journal:  Infect Immun       Date:  2007-05-21       Impact factor: 3.441

Review 7.  Buruli ulcer disease: prospects for a vaccine.

Authors:  Kris Huygen; Ohene Adjei; Dissou Affolabi; Gisela Bretzel; Caroline Demangel; Bernhard Fleischer; Roch Christian Johnson; Jorge Pedrosa; Delphin M Phanzu; Richard O Phillips; Gerd Pluschke; Vera Siegmund; Mahavir Singh; Tjip S van der Werf; Mark Wansbrough-Jones; Françoise Portaels
Journal:  Med Microbiol Immunol       Date:  2009-02-07       Impact factor: 3.402

8.  Illness meanings and experiences for pre-ulcer and ulcer conditions of Buruli ulcer in the Ga-West and Ga-South Municipalities of Ghana.

Authors:  Mercy M Ackumey; Margaret Gyapong; Matilda Pappoe; Cynthia Kwakye-Maclean; Mitchell G Weiss
Journal:  BMC Public Health       Date:  2012-05-11       Impact factor: 3.295

9.  Buruli ulcer, Nigeria.

Authors:  Okechukwu Chukwuekezie; Edwin Ampadu; Ghislain Sopoh; Ange Dossou; Alexandre Tiendrebeogo; Lola Sadiq; Françoise Portaels; Kingsley Asiedu
Journal:  Emerg Infect Dis       Date:  2007-05       Impact factor: 6.883

10.  Implementation of a national reference laboratory for Buruli ulcer disease in Togo.

Authors:  Marcus Beissner; Kristina Lydia Huber; Kossi Badziklou; Wemboo Afiwa Halatoko; Issaka Maman; Felix Vogel; Bawimodom Bidjada; Koffi Somenou Awoussi; Ebekalisai Piten; Kerstin Helfrich; Carolin Mengele; Jörg Nitschke; Komi Amekuse; Franz Xaver Wiedemann; Adolf Diefenhardt; Basile Kobara; Karl-Heinz Herbinger; Abiba Banla Kere; Mireille Prince-David; Thomas Löscher; Gisela Bretzel
Journal:  PLoS Negl Trop Dis       Date:  2013-01-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.